Trauma Study Aims to Improve Survival for Bleeding Patients

May 28, 2022 at 10:05 am by Staff

Emergency Medicine and Trauma Surgery researchers at Vanderbilt University Medical Center (VUMC) are joining Vanderbilt LifeFlight in a Department of Defense (DOD)-f.... Read More

Misconceptions About Hospice Care: It’s About Quality of Life, Not Imminent Death

May 25, 2022 at 09:09 pm by Staff

Between 1.3 million and 1.7 million patients in the U.S. were cared for annually through hospice services from 2009-2020. But many people continue to have mispe.... Read More

‘Almost Like Malpractice’: To Shed Bias, Doctors Get Schooled to Look Beyond Obesity

May 24, 2022 at 11:23 am by Staff

By Lauren Sausser, Kaiser Health News When Melissa Boughton complained to her OB-GYN about dull pelvic pain, the doctor responded by asking about her diet and exercise h.... Read More

FDA Approves First Treatment for Eosinophilic Esophagitis

May 23, 2022 at 09:21 pm by Staff

  The U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and old.... Read More

‘That’s Just Part of Aging’: Long Covid Symptoms Are Often Overlooked in Seniors

May 23, 2022 at 08:41 pm by Staff

By Judith Graham, Kaiser Health News Nearly 18 months after getting covid-19 and spending weeks in the hospital, Terry Bell struggles with hanging up his shirts an.... Read More

Why Won’t More Older Americans Get Their Covid Booster?

May 23, 2022 at 08:12 pm by Staff

By Liz Szabo, Kaiser Health News Even as top U.S. health officials say it’s time America learns to live with the coronavirus, a chorus of leading re.... Read More

A Clue to an Adverse Drug Event in Children

May 20, 2022 at 11:00 pm by Staff

by Joshua Baker One in six children with congenital heart disease experience supraventricular tachycardia, a fast or erratic heartbeat that affects the heart’s upper ch.... Read More

FDA Expands Eligibility for Pfizer-BioNTech COVID Booster for Children 5 through 11 Years

May 17, 2022 at 10:02 am by Staff

Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster do.... Read More

Resistance to COVID-19 drug detected in Lab Study

May 16, 2022 at 08:37 pm by Staff

by Bill Snyder The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more tha.... Read More

Study sheds light on the dark side of Obesity

May 15, 2022 at 04:18 pm by Staff

  by Bill Snyder Obesity is an inflammatory condition that can damage tissues throughout the body, resulting in increased risk for cardiovascular disease, insulin resis.... Read More